/PRNewswire/ Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the.
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE .